Magnesium intake and prevalence of metabolic syndrome in adults: Tehran lipid and glucose study

Public Health Nutrition

Volumn 15, Issue 4, 2012, Pages 693-701

  Mirmiran, Parvin ^a,b   Shab Bidar, Sakineh ^a   Hosseini Esfahani, Firoozeh ^a   Asghari, Golaleh ^a   Hosseinpour Niazi, Somayeh ^a   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adults; Magnesium intake; Metabolic syndrome; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE POLICY; HUMAN; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; MAGNESIUM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION POLICY; NUTRITION SURVEYS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84857947751     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980011002941     Document Type: Article

References (48)

1. Barbagallo M & Dominguez LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458, 40-47 (Pubitemid 46186226)
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421
3. Alberti K, Eckel RH, Grundy SM et al. (2009) Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645
4. Azizi F, Salehi P, Etemadi A et al. (2003) Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61, 29-37 (Pubitemid 36808841)
5. Saris NE, Mervaala E, Karppanen H et al. (2000) Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294, 1-26 (Pubitemid 30155803)
6. Salmeron J, Ascherio A, Rimm EB et al. (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20, 545-550 (Pubitemid 27143413)
7. Ascherio A, Rimm EB, Giovannucci EL et al. (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475-1484
8. Ascherio A, Hennekens C, Willett WC et al. (1996) Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27, 1065-1072 (Pubitemid 26140662)
9. Abbott RD, Ando F, Masaki KH et al. (2003) Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 92, 665-669 (Pubitemid 37103015)
10. Al-Delaimy WK, Rimm EB, Willett WC et al. (2004) Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23, 63-70 (Pubitemid 38200836)
11. Song Y, Manson JE, Buring JE et al. (2004) Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27, 59-65 (Pubitemid 38196710)
12. Altura BM & Altura BT (1995) Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 41, 347-359
13. Rasmussen HS, Aurup P, Goldstein K et al. (1989) Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 149, 1050-1053 (Pubitemid 19131829)
14. He K, Liu K, Daviglus ML et al. (2006) Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113, 1675-1682
15. McKeown NM, Jacques PF, Zhang XL et al. (2008) Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr 47, 210-216
16. Sonnenberg L, Pencina M, Kimokoti R et al. (2005) Dietary patterns and the metabolic syndrome in obese and nonobese Framingham women. Obes Res 13, 153-162
17. van Dam RM, Hu FB, Rosenberg L et al. (2006) Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 29, 2238-2243 (Pubitemid 44899858)
18. Ghassemi H, Harrison G & Mohammad K (2002) An accelerated nutrition transition in Iran. Public Health Nutr 5, 149-155 (Pubitemid 41128301)
19. Azizi F, Rahmani M, Emami H et al. (2002) Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1). Soz Praventivmed 47, 408-426 (Pubitemid 36285040)
20. Hosseini-Esfahani F, Jessri M, Mirmiran P et al. (2010) Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism 59, 1833-1842
21. Kriska AM, Knowler WC, LaPorte RE et al. (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13, 401-411 (Pubitemid 20109476)
22. Ainsworth BE, Haskell WL, Whitt MC et al. (2000) Compendium of physical activities: An update of activity codes and MET intensities. Med Sci Sports Exerc 32, 9 Suppl., S498-S504
23. Mirmiran P, Esfahani FH, Mehrabi Y et al. (2009) Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr 13, 654-662
24. Ghaffarpour M, Houshiar-Rad A & Kianfar H (1999) The Manual for Household Measures, Cooking Yields Factors and Edible Portion of Food. Tehran: Keshaverzi Press
25. Azar MSE (1980) Food Composition Table of Iran. Tehran: National Nutrition and Food Research Institute, Shahid Beheshti University
26. US Department of Agriculture, Agricultural Research Service (2006) Food Composition Table (FCT). http://www. nal.usda.gov/fnic/foodcomp (accessed December 2009)
27. Azizi F, Ghanbarian A, Madjid M et al. (2002) Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Hum Hypertens 16, 305-312 (Pubitemid 34537398)
28. Azizi F, Ghanbarian A, Momenan AA et al. (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10, 5
29. Azizi F, Hadaegh F, Khalili D et al. (2010) Appropriate definition of metabolic syndrome among Iranian adults: Report of the Iranian National Committee of Obesity. Arch Iran Med 13, 426-428
30. Franks PW, Ekelund U, Brage S et al. (2004) Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitnesŝ Diabetes Care 27, 1187-1193 (Pubitemid 38579788)
31. Ford ES, Li C, McGuire LC et al. (2007) Intake of dietary magnesium and the prevalence of the metabolic syndrome among US adults. Obesity (Silver Spring) 15, 1139-1146 (Pubitemid 46932468)
32. Bo S, Durazzo M, Guidi S et al. (2006) Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr 84, 1062-1069 (Pubitemid 44730376)
33. Song Y, Li TY, van Dam RM et al. (2007) Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85, 1068-1074 (Pubitemid 46557923)
34. Yokota K, Kato M, Lister F et al. (2004) Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 23, issue 5, 506S-509S
35. Paolisso G, Sgambato S, Pizza G et al. (1989) Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12, 265-269 (Pubitemid 19092236)
36. de Valk HW (1999) Magnesium in diabetes mellitus. Neth J Med 54, 139-146 (Pubitemid 29148073)
37. Ma J, Folsom AR, Melnick SL et al. (1995) Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48, 927-940
38. Itoh K, Kawasaka T & Nakamura M (1997) The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 78, 737-750 (Pubitemid 27483017)
39. Guerrero-Romero F & Rodriguez-Moran M (2002) Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39, 209-213 (Pubitemid 35470535)
40. Rayssiguier Y, Noe L, Etienne J et al. (1991) Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat. Lipids 26, 182-186
41. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497
42. Corica F, Corsonello A, Ientile R et al. (2006) Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25, 210-215 (Pubitemid 46939845)
43. Drenick EJ (1961) The influence of ingestion of calcium and other soap-forming substances on fecal fat. Gastroenterology 41, 242-244
44. Liu S, Willett WC, Manson JE et al. (2003) Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78, 920-927 (Pubitemid 39663467)
45. O'Byrne DJ, Knauft DA & Shireman RB (1997) Low fatmonounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles. Lipids 32, 687-695 (Pubitemid 27328049)
46. Slavin JL, Martini MC, Jacobs DR Jr et al. (1999) Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr 70, 3 Suppl., 459S-463S (Pubitemid 29407124)
47. Halliwell B (2000) The antioxidant paradox. Lancet 355, 1179-1180 (Pubitemid 30172947)
48. Kao WH, Folsom AR, Nieto FJ et al. (1999) Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 159, 2151-2159. (Pubitemid 29483154)